Toxoplasmosis in pregnancy.
Wong
S Y
SY
Department of Immunology and Infectious Diseases, Research Institute, Palo Alto Medical Foundation, California.
Remington
J S
JS
D000818:Animals; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D015597:Pregnancy Complications, Parasitic / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D011739:Pyrimethamine / Q000627:therapeutic use; D015572:Spiramycin / Q000627:therapeutic use; D013411:Sulfadiazine / Q000627:therapeutic use; D014122:Toxoplasma; D014123:Toxoplasmosis / Q000150:complications* / Q000188:drug therapy / Q000453:epidemiology / Q000635:transmission; D014125:Toxoplasmosis, Congenital / Q000517:prevention & control*
D013411:Sulfadiazine; D015572:Spiramycin; D011739:Pyrimethamine